PL348152A1 - Use of benzoylguanidines for the treatment of non-insulin-dependent diabetes mellitus - Google Patents

Use of benzoylguanidines for the treatment of non-insulin-dependent diabetes mellitus

Info

Publication number
PL348152A1
PL348152A1 PL99348152A PL34815299A PL348152A1 PL 348152 A1 PL348152 A1 PL 348152A1 PL 99348152 A PL99348152 A PL 99348152A PL 34815299 A PL34815299 A PL 34815299A PL 348152 A1 PL348152 A1 PL 348152A1
Authority
PL
Poland
Prior art keywords
benzoylguanidines
insulin
treatment
diabetes mellitus
dependent diabetes
Prior art date
Application number
PL99348152A
Other languages
English (en)
Inventor
Rolf Gericke
Manfred Baumgarth
Klaus Minck
Didier Mesangeau
Liliane Doare
Micheline Kergoat
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL348152A1 publication Critical patent/PL348152A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4021-aryl substituted, e.g. piretanide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL99348152A 1998-11-26 1999-11-16 Use of benzoylguanidines for the treatment of non-insulin-dependent diabetes mellitus PL348152A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98122419 1998-11-26

Publications (1)

Publication Number Publication Date
PL348152A1 true PL348152A1 (en) 2002-05-06

Family

ID=8233036

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99348152A PL348152A1 (en) 1998-11-26 1999-11-16 Use of benzoylguanidines for the treatment of non-insulin-dependent diabetes mellitus

Country Status (14)

Country Link
EP (1) EP1131064A2 (id)
JP (1) JP2002530325A (id)
KR (1) KR20010080597A (id)
CN (1) CN1328452A (id)
AR (1) AR023064A1 (id)
AU (1) AU1553500A (id)
BR (1) BR9915667A (id)
CA (1) CA2352154A1 (id)
CZ (1) CZ20011785A3 (id)
HU (1) HUP0104418A2 (id)
ID (1) ID29523A (id)
NO (1) NO20012563L (id)
PL (1) PL348152A1 (id)
WO (1) WO2000030624A2 (id)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003103648A1 (ja) * 2002-06-05 2003-12-18 株式会社医薬分子設計研究所 糖尿病治療薬
US7381841B2 (en) 2003-08-22 2008-06-03 Sanofi-Aventis Deutschland Gmbh Pentafluorosulfanylphenyl-substituted benzoylguanidines, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them
DE102004054847A1 (de) * 2004-11-13 2006-05-24 Sanofi-Aventis Deutschland Gmbh Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4430861A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
DE4430916A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Alkyl-benzoylguanidin-Derivate
DE4437874A1 (de) * 1994-10-22 1996-04-25 Merck Patent Gmbh Alkyl-5-methylsulfonyl-benzoylguanidin-Derivate
DE19502644A1 (de) * 1995-01-28 1996-08-01 Merck Patent Gmbh 4-Amino-benzoylguanidin-Derivate
DE19502895A1 (de) * 1995-01-31 1996-08-01 Merck Patent Gmbh 4-Mercapto-benzoylguanidin-Derivate
DE19517848A1 (de) * 1995-05-16 1996-11-21 Merck Patent Gmbh Fluorhaltige Benzoylguanidine
DE19531138A1 (de) * 1995-08-24 1997-02-27 Merck Patent Gmbh Alkenyl-benzoylguanidin-Derivate

Also Published As

Publication number Publication date
NO20012563D0 (no) 2001-05-25
AU1553500A (en) 2000-06-13
EP1131064A2 (en) 2001-09-12
CN1328452A (zh) 2001-12-26
NO20012563L (no) 2001-05-25
CZ20011785A3 (cs) 2001-10-17
CA2352154A1 (en) 2000-06-02
ID29523A (id) 2001-09-06
KR20010080597A (ko) 2001-08-22
JP2002530325A (ja) 2002-09-17
BR9915667A (pt) 2001-08-14
AR023064A1 (es) 2002-09-04
HUP0104418A2 (hu) 2002-04-29
WO2000030624A2 (en) 2000-06-02
WO2000030624A3 (en) 2000-10-05

Similar Documents

Publication Publication Date Title
HK1045111A1 (en) (3-Trihalomethylphenoxy) (4-halophenyl) for the treatment of insulin reisistance and type 2 diabetes
AU6865298A (en) The use of cryoprotective agent compounds during cryosurgery
IL130027A (en) Rosiglitazone - glyburide synergistic combinations for treatment of diabetes
HUP0003265A3 (en) Nutritional composition for the treatment of pressure ulcers
AU6257599A (en) Non-invasive blood component analyzer
HUP0002196A3 (en) Medical food for diabetics
EP1115422A4 (en) USE OF NON-PEPTIDYLIC COMPOUNDS FOR THE TREATMENT OF INSULIN-RELATED CONDITIONS
AU1450900A (en) Methods of treatment of type 2 diabetes
IL116234A0 (en) Fungicidal compounds
ZA953336B (en) Substituted sulfonamides as selective B3 agonists for the treatment of diabetes and obesity
HUP0003428A3 (en) Use of leptin antagonists for the treatment of diabetes
AU1405595A (en) Use of thalidomide for the treatment of non-insulin dependent diabetes mellitus
PL348152A1 (en) Use of benzoylguanidines for the treatment of non-insulin-dependent diabetes mellitus
AU2205099A (en) Chimeric proteins for the treatment of diabetes
IL132032A0 (en) Retinoid related molecules for the treatment of non-insulin dependent diabetes mellitus
AU3344499A (en) Hypoglycemic agents
AU6258894A (en) Chimeric gene using the gene or cdna of insuline, specially for the gene therapy of diabetes
GB2355189B (en) Herbal preparation for the treatment of diabetes mellitus
AU3117497A (en) Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
IL130831A0 (en) Imino-aza-anthracylinone derivatives for the treatment of amyloidosis
GB9417620D0 (en) Water soluble biocide for medical instruments with wide spectrum activity
GB9808755D0 (en) Fungicidal use
GB9808254D0 (en) Flexible endoscope cover
HRP980066B1 (en) Sulfonamide substituted compounds, processes for their preparation, their use as medicins or diagnostic agents as well as the medicine containing them
AU6256599A (en) Flexible disposable container